Pharmaceutical Business Competition in Indonesia: A Review
Abstract
Heri Erlangga, Wa Ode Sifatu, Dimas Wibisono, Ade Onny Siagian, Rudi Salam, Mahnun Masâadi, Gunartin, Riri Oktarini, Cornelia Dumarya Manik, Nani, Ahmad Nurhadi, Denok Sunarsi, Agus Purwanto, Gatot Kusjono
The pharmaceutical industry scored a profit year on year (yoy) at a pandemic period of 10.3% while other companies were confirmed to be losing money. With the advancement of the times and the advancement of technology it is expected that pharmaceutical companies will survive to serve their consumers. product diversity strategies, managing the effectiveness of sales and marketing activities, and transforming the utilization of digital technology, are carried out so that pharmaceutical companies can serve business consumers to their businesses; i.e. pharmacies and drugstores; then pharmacies and drugstores can serve consumers eventually. In this paper, researchers used a qualitative approach to literature study methods. Where researchers collect writings or articles, books and all forms of sources related to research objects. The data is processed and analyzed to obtain a form of research results. In this paper, researchers consider the business strategies of pharmaceutical companies in Indonesia. The purpose of this research is to understand the competition of the pharmaceutical business with its marketing strategy in this era of intense competition. Changes in consumer behavior and the demand for a service more than the company usually provides, gaining momentum to create breakthrough services and products that suit consumers' wishes and are renewed. Absolute consumer satisfaction of the price that must be given by pharmaceutical companies or pharmacies in order for consumers to remain loyal to the company's products and services. Ease of technology, investment, and information become commonplace in an era of super-tight competition.
| How to Cite this Article |
| Pubmed Style Erlangga H, Sifatu WO, Wibisono D, Siagian AO, Salam R, Mas'adi M, Gunartin , Oktarini R, Manik CD, Nani , Nurhadi A, Sunarsi D, Purwanto A, Kusjono G. Pharmaceutical Business Competition in Indonesia: A Review. SRP. 2020; 11(10): 617-623. doi:10.31838/srp.2020.10.92 Web Style Erlangga H, Sifatu WO, Wibisono D, Siagian AO, Salam R, Mas'adi M, Gunartin , Oktarini R, Manik CD, Nani , Nurhadi A, Sunarsi D, Purwanto A, Kusjono G. Pharmaceutical Business Competition in Indonesia: A Review. http://www.sysrevpharm.org/?mno=3397 [Access: March 30, 2021]. doi:10.31838/srp.2020.10.92 AMA (American Medical Association) Style Erlangga H, Sifatu WO, Wibisono D, Siagian AO, Salam R, Mas'adi M, Gunartin , Oktarini R, Manik CD, Nani , Nurhadi A, Sunarsi D, Purwanto A, Kusjono G. Pharmaceutical Business Competition in Indonesia: A Review. SRP. 2020; 11(10): 617-623. doi:10.31838/srp.2020.10.92 Vancouver/ICMJE Style Erlangga H, Sifatu WO, Wibisono D, Siagian AO, Salam R, Mas'adi M, Gunartin , Oktarini R, Manik CD, Nani , Nurhadi A, Sunarsi D, Purwanto A, Kusjono G. Pharmaceutical Business Competition in Indonesia: A Review. SRP. (2020), [cited March 30, 2021]; 11(10): 617-623. doi:10.31838/srp.2020.10.92 Harvard Style Erlangga, H., Sifatu, . W. O., Wibisono, . D., Siagian, . A. O., Salam, . R., Mas'adi, . M., Gunartin, ., Oktarini, . R., Manik, . C. D., Nani, ., Nurhadi, . A., Sunarsi, . D., Purwanto, . A. & Kusjono, . G. (2020) Pharmaceutical Business Competition in Indonesia: A Review. SRP, 11 (10), 617-623. doi:10.31838/srp.2020.10.92 Turabian Style Erlangga, Heri, Wa Ode Sifatu, Dimas Wibisono, Ade Onny Siagian, Rudi Salam, Mahnun Mas'adi, Gunartin, Riri Oktarini, Cornelia Dumarya Manik, Nani, Ahmad Nurhadi, Denok Sunarsi, Agus Purwanto, and Gatot Kusjono. 2020. Pharmaceutical Business Competition in Indonesia: A Review. Systematic Reviews in Pharmacy, 11 (10), 617-623. doi:10.31838/srp.2020.10.92 Chicago Style Erlangga, Heri, Wa Ode Sifatu, Dimas Wibisono, Ade Onny Siagian, Rudi Salam, Mahnun Mas'adi, Gunartin, Riri Oktarini, Cornelia Dumarya Manik, Nani, Ahmad Nurhadi, Denok Sunarsi, Agus Purwanto, and Gatot Kusjono. "Pharmaceutical Business Competition in Indonesia: A Review." Systematic Reviews in Pharmacy 11 (2020), 617-623. doi:10.31838/srp.2020.10.92 MLA (The Modern Language Association) Style Erlangga, Heri, Wa Ode Sifatu, Dimas Wibisono, Ade Onny Siagian, Rudi Salam, Mahnun Mas'adi, Gunartin, Riri Oktarini, Cornelia Dumarya Manik, Nani, Ahmad Nurhadi, Denok Sunarsi, Agus Purwanto, and Gatot Kusjono. "Pharmaceutical Business Competition in Indonesia: A Review." Systematic Reviews in Pharmacy 11.10 (2020), 617-623. Print. doi:10.31838/srp.2020.10.92 APA (American Psychological Association) Style Erlangga, H., Sifatu, . W. O., Wibisono, . D., Siagian, . A. O., Salam, . R., Mas'adi, . M., Gunartin, ., Oktarini, . R., Manik, . C. D., Nani, ., Nurhadi, . A., Sunarsi, . D., Purwanto, . A. & Kusjono, . G. (2020) Pharmaceutical Business Competition in Indonesia: A Review. Systematic Reviews in Pharmacy, 11 (10), 617-623. doi:10.31838/srp.2020.10.92 |
Abstract
PDF
How to cite this article
Related Records